NVP-AEW541
NVP-AEW541 (AEW541) is an orally active inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with an IC50 value of 0.15 μM. NVP-AEW541 also inhibits InsR, IC50 with a value of 0.14 μM. NVP-AEW541 has antitumor activity[1].
Product Specifications
CAS Number
475489-16-8
Product Name Alternative
AEW541
UNSPSC
12352005
Hazard Statement
H315, H319
Target
Autophagy; IGF-1R; Insulin Receptor
Type
Reference compound
Related Pathways
Autophagy; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Endocrinology
Assay Protocol
https://www.medchemexpress.com/NVP-AEW541.html
Purity
99.92
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
NC1=C2C(N([C@@H]3C[C@@H](C3)CN4CCC4)C=C2C5=CC=CC(OCC6=CC=CC=C6)=C5)=NC=N1
Molecular Formula
C27H29N5O
Molecular Weight
439.55
Precautions
H315, H319
References & Citations
[1]García-Echeverría C, et al. In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell. 2004 Mar;5 (3) :231-9.|[2]Tanno B, et al. Down-regulation of IGF-1 receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo. Clin Cancer Res. 2006, 12 (22), 6772-6780.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP303330M 100 µg
Peroxiredoxin 4 (PRDX4) (NM_006406) Human Recombinant Protein
Sign In for Pricing
View Details 
LC420068 20 µg
BubR1 (BUB1B) (NM_001211) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC881556-500 1x 500 µL
Ep-CAM / CD326 (Epithelial Marker) (EGP40/1556R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
